60 related articles for article (PubMed ID: 36325600)
1. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
2. Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia - A systematic review.
Santana NCM; de Sena ACVP; Rocha PADS; de Arruda JAA; Torres-Pereira CC; Abreu LG; Fournier BPJ; Warnakulasuriya S; Silva TA
Oral Oncol; 2024 Mar; 150():106699. PubMed ID: 38309198
[TBL] [Abstract][Full Text] [Related]
3. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.
Bates T; Kennedy M; Diajil A; Goodson M; Thomson P; Doran E; Farrimond H; Thavaraj S; Sloan P; Kist R; Robinson M
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):927-35. PubMed ID: 27197272
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.
Paglioni MP; Khurram SA; Ruiz BII; Lauby-Secretan B; Normando AG; Ribeiro ACP; Brandão TB; Palmier NR; Lopes MA; da Silva Guerra EN; Meleti M; Migliorati CA; Carvalho AL; de Matos LL; Kowalski LP; Santos-Silva AR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):573-587. PubMed ID: 36153299
[TBL] [Abstract][Full Text] [Related]
5. Leveraging artificial intelligence for perioperative cancer risk assessment of oral potentially malignant disorders.
Adeoye J; Su YX
Int J Surg; 2024 Mar; 110(3):1677-1686. PubMed ID: 38051932
[TBL] [Abstract][Full Text] [Related]
6. State of the Art in the Diagnosis and Assessment of Oral Malignant and Potentially Malignant Disorders: Present Insights and Future Outlook-An Overview.
Menditti D; Santagata M; Guida D; Magliulo R; D'Antonio GM; Staglianò S; Boschetti CE
Bioengineering (Basel); 2024 Feb; 11(3):. PubMed ID: 38534502
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders.
Viglianisi G; Polizzi A; Grippaudo C; Cocuzza S; Leonardi R; Isola G
Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247942
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.
Ai R; Tao Y; Hao Y; Jiang L; Dan H; Ji N; Zeng X; Zhou Y; Chen Q
Oncotarget; 2017 Oct; 8(46):81617-81635. PubMed ID: 29113419
[TBL] [Abstract][Full Text] [Related]
9. How ChatGPT performs in Oral Medicine: The case of oral potentially malignant disorders.
Diniz-Freitas M; Rivas-Mundiña B; García-Iglesias JR; García-Mato E; Diz-Dios P
Oral Dis; 2024 May; 30(4):1912-1918. PubMed ID: 37794649
[No Abstract] [Full Text] [Related]
10. Editorial: Reviews in the prevention and early detection of oral cancers.
Jha AK
Front Oral Health; 2024; 5():1362945. PubMed ID: 38505805
[No Abstract] [Full Text] [Related]
11. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
[TBL] [Abstract][Full Text] [Related]
12. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma.
Dalley AJ; Pitty LP; Major AG; Abdulmajeed AA; Farah CS
Cancer Med; 2014 Apr; 3(2):273-83. PubMed ID: 24415717
[TBL] [Abstract][Full Text] [Related]
13. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
[TBL] [Abstract][Full Text] [Related]
14. Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder.
Lorenzo-Pouso AI; Lafuente-Ibáñez de Mendoza I; Pérez-Sayáns M; Pérez-Jardón A; Chamorro-Petronacci CM; Blanco-Carrión A; Aguirre-Urízar JM
J Oral Pathol Med; 2022 Aug; 51(7):585-593. PubMed ID: 35488780
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
16. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.
Tarle M; Raguž M; Muller D; Lukšić I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982894
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
